syngo.via – Clinical
High-quality image access on the go - with syngo.via WebViewer
syngo.via WebViewer2 is the ideal solution for fast and easy image access.
Radiologists often need to take a quick look at images in time critical cases but might not be in front of a workstation or not even on the hospital campus. Also clinicians outside the radiology department sometimes depend on time consuming walks over to a radiology department for image access.
With syngo.via WebViewer, radiologists and physicians can contribute to patient care virtually anywhere, anytime1. They can access the images directly on a computer connected to a diagnostic grade monitor for a second opinion.
Image access from outside radiology also helps smoothen collaboration between radiologists and internal referrers. With syngo.via WebViewer you can illustrate and discuss results with patients, clearly, confidently and convincingly - without the need for a workstation, directly at the bedside.
1Prerequisites include: connection to clinical network, meeting recommended minimum hardware requirements, and adherence to local data security regulations.
2The application syngo.via WebViewer is not for diagnostic viewing/reading on mobile devices in the US. Diagnostic reading of images with a web browser requires a medical grade monitor. For iPhone and iPad, country specific laws may apply. Please refer to these laws before using for diagnostic reading/viewing. Please contact your sales representative to determine whether the product is available in your country. For Japan: Applications on iPhone / iPad / iPod are not considered medical devices in Japan. Use at your own risk. They are not intended to be used for diagnosis.
3syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via is not yet commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further information.